{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:45:01Z","timestamp":1789620301052,"version":"build-2803163510"},"reference-count":252,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Dementia is a neurodegenerative condition marked by progressive cognitive decline, which affects people worldwide. Studies on dementia typically continue over years of uncertainty. Different types of dementia, like Alzheimer\u2019s disease dementia, Lewy body dementia, frontotemporal dementia, and vascular dementia, exhibit different pathological features, yet their downstream inflammatory pathways involve similar inflammatory mediators. As an initial trigger, microglial cells and astrocytes become activated by protein aggregates, mutations, or any other cause, and release pro-inflammatory cytokines, which can lead to synaptic dysfunction, neuronal degeneration, and impaired cognitive function. Neuroinflammation plays a critical role in the pathogenesis of all forms of dementia. Despite their distinct neuropathological features, inflammatory processes may coincide at a point and lead to neuronal degeneration and cognitive decline. Recent advancements in neuroimaging techniques and biomarker discovery revealed potential therapeutic targets that may mitigate neuroinflammation. The primary objective of this review is to explore the underlying mechanisms linking neuroinflammation to various types of dementia. This review focuses on shared and distinct neuroinflammatory mechanisms to unravel significant therapeutic strategies for dementia.<\/jats:p>","DOI":"10.3390\/ijms27010179","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T09:58:34Z","timestamp":1766570314000},"page":"179","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Shared Neuroinflammatory Mechanisms Across Dementia Types: An Integrative Review"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8719-5827","authenticated-orcid":false,"given":"Subramanian","family":"Thangaleela","sequence":"first","affiliation":[{"name":"Department of Nutrition, Chung Shan Medical University, 110, Sec. 1, Jianguo North Road, Taichung City 40201, Taiwan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0370-1438","authenticated-orcid":false,"given":"Asif","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Nutrition, Chung Shan Medical University, 110, Sec. 1, Jianguo North Road, Taichung City 40201, Taiwan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohanes","family":"Tandoro","sequence":"additional","affiliation":[{"name":"Faculty of Agricultural Technology, Widya Mandala Catholic University Surabaya, Surabaya 6026, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5371-7847","authenticated-orcid":false,"given":"Chin-Kun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nutrition, Chung Shan Medical University, 110, Sec. 1, Jianguo North Road, Taichung City 40201, Taiwan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"360","DOI":"10.7326\/0003-4819-159-7-201310010-00688","article-title":"The DSM-5 and the art of medicine: Certainly uncertain","volume":"159","author":"McCarron","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"ref_2","unstructured":"(2024, September 19). Dementia. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e12802","DOI":"10.1111\/acel.12802","article-title":"Aging and Alzheimer\u2019s disease: Comparison and associations from molecular to system level","volume":"17","author":"Xia","year":"2018","journal-title":"Aging Cell"},{"key":"ref_4","unstructured":"Alzheimer\u2019s Association (2025). 2025 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement., 21, e70235."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.jalz.2018.06.3061","article-title":"Stroke and dementia risk: A systematic review and meta-analysis","volume":"14","author":"Lourida","year":"2018","journal-title":"Alzheimer\u2019s Dement. J. Alzheimer\u2019s Assoc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/jama.2018.11499","article-title":"Association of Cardiovascular Health Level in Older Age with Cognitive Decline and Incident Dementia","volume":"320","author":"Samieri","year":"2018","journal-title":"JAMA"},{"key":"ref_7","unstructured":"WHO (2017). Global Action Plan on the Public Health Response to Dementia 2017\u20132025, Mental Health, Brain Health and Substance Use (MSD), World Health Organisation."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Huang, L., and Aronow, W.S. (2024). Association of hypertension with different cognitive disorders. J. Clin. Med., 13.","DOI":"10.3390\/jcm13206029"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimer\u2019s Dement. J. Alzheimer\u2019s Assoc."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jama.2019.4782","article-title":"Diagnosis and Management of Dementia: Review","volume":"322","author":"Arvanitakis","year":"2019","journal-title":"JAMA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimer\u2019s Dement. J. Alzheimer\u2019s Assoc."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Wright, A.L., Zinn, R., Hohensinn, B., Konen, L.M., Beynon, S.B., Tan, R.P., Clark, I.A., Abdipranoto, A., and Vissel, B. (2013). Neuroinflammation and neuronal loss precede A\u03b2 plaque deposition in the hAPP-J20 mouse model of Alzheimer\u2019s disease. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059586"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.0306164","article-title":"DAMPs, PAMPs and alarmins: All we need to know about danger","volume":"81","author":"Bianchi","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.it.2007.08.004","article-title":"Inside, outside, upside down: Damage-associated molecular-pattern molecules (DAMPs) and redox","volume":"28","author":"Rubartelli","year":"2007","journal-title":"Trends Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1159\/000334916","article-title":"Neuroinflammation and blood-brain barrier changes in capillary amyloid angiopathy","volume":"10","author":"Carrano","year":"2012","journal-title":"Neuro-Degener. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"480739","DOI":"10.1155\/2013\/480739","article-title":"Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain","volume":"2013","author":"Ramesh","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2014.07.012","article-title":"Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases","volume":"274","author":"Elgueta","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neuint.2008.06.005","article-title":"Interactions between the amyloid and cholinergic mechanisms in Alzheimer\u2019s disease","volume":"53","year":"2008","journal-title":"Neurochem. Int."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.14283\/jpad.2018.43","article-title":"Revisiting the Cholinergic Hypothesis in Alzheimer\u2019s Disease: Emerging Evidence from Translational and Clinical Research","volume":"6","author":"Hampel","year":"2019","journal-title":"J. Prev. Alzheimer\u2019s Dis."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Opris, I., Nestianu, V.S., Nestianu, A., Bilteanu, L., and Ciurea, J. (2017). George Marinesco in the Constellation of Modern Neuroscience. Front. Neurosci., 11.","DOI":"10.3389\/fnins.2017.00726"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3233\/JAD-140276","article-title":"Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates","volume":"42","author":"Bondi","year":"2014","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.25122\/jml-2022-0111","article-title":"Alzheimer\u2019s disease: 120 years of research and progress","volume":"16","author":"Ciurea","year":"2023","journal-title":"J. Med. Life"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41531-021-00213-7","article-title":"Genetic and environmental factors in Alzheimer\u2019s and Parkinson\u2019s diseases and promising therapeutic intervention via fecal microbiota transplantation","volume":"7","author":"Wang","year":"2021","journal-title":"npj Park. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Breijyeh, Z., and Karaman, R. (2020). Comprehensive Review on Alzheimer\u2019s Disease: Causes and Treatment. Molecules, 25.","DOI":"10.3390\/molecules25245789"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/978-94-007-5416-4_14","article-title":"Alzheimer\u2019s disease","volume":"65","author":"Radanovic","year":"2012","journal-title":"Sub-Cell. Biochem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.neuron.2014.05.004","article-title":"The intersection of amyloid beta and tau at synapses in Alzheimer\u2019s disease","volume":"82","author":"Hyman","year":"2014","journal-title":"Neuron"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.febslet.2004.06.025","article-title":"Abeta production as consequence of cellular death of a human neuroblastoma overexpressing APP","volume":"3","author":"Recuero","year":"2004","journal-title":"FEBS Lett."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.mehy.2006.02.023","article-title":"Protein ubiquitination, degradation and the proteasome in neuro-degenerative disorders: No clear evidence for a significant pathogenetic role of proteasome failure in Alzheimer disease and related disorders","volume":"67","author":"Schmitt","year":"2006","journal-title":"Med. Hypotheses"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Barbier, P., Zejneli, O., Martinho, M., Lasorsa, A., Belle, V., Smet-Nocca, C., Tsvetkov, P.O., Devred, F., and Landrieu, I. (2019). Role of Tau as a Microtubule-Associated Protein: Structural and Functional Aspects. Front. Aging Neurosci., 11.","DOI":"10.3389\/fnagi.2019.00204"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(13)70090-5","article-title":"Tau pathology and neurodegeneration","volume":"12","author":"Spillantini","year":"2013","journal-title":"Lancet. Neurol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/0891988710383571","article-title":"Genetics of Alzheimer disease","volume":"23","author":"Bekris","year":"2010","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/archneur.63.9.1307","article-title":"Early-onset Alzheimer disease in families with late-onset Alzheimer disease: A potential important subtype of familial Alzheimer disease","volume":"63","author":"Brickell","year":"2006","journal-title":"Arch. Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1016\/j.ajpath.2012.02.012","article-title":"Presenilin-1 L166P mutant human pluripotent stem cell-derived neurons exhibit partial loss of \u03b3-secretase activity in endogenous amyloid-\u03b2 generation","volume":"180","author":"Koch","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.20142322","article-title":"TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer\u2019s disease mouse models","volume":"212","author":"Jay","year":"2015","journal-title":"J. Exp. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1742-4933-6-13","article-title":"Pathophysiology of vascular dementia","volume":"6","author":"Iemolo","year":"2009","journal-title":"Immun. Ageing"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.bbadis.2016.01.015","article-title":"Stroke injury, cognitive impairment and vascular dementia","volume":"1862","author":"Kalaria","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Yang, H.M. (2025). Vascular Dementia: From Pathophysiology to Therapeutic Frontiers. J. Clin. Med., 14.","DOI":"10.3390\/jcm14186611"},{"key":"ref_40","first-page":"e272","article-title":"Cognitive Impairment After Ischemic and Hemorrhagic Stroke: A Scientific Statement from the American Heart Association\/American Stroke Association","volume":"54","author":"Katzan","year":"2023","journal-title":"Stroke"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"102278","DOI":"10.1016\/j.arr.2024.102278","article-title":"Vascular dementia: From pathobiology to emerging perspectives","volume":"96","author":"Morgan","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1212\/WNL.42.6.1185","article-title":"Dementia after stroke: Baseline frequency, risks, and clinical features in a hospitalized cohort","volume":"42","author":"Tatemichi","year":"1992","journal-title":"Neurology"},{"key":"ref_43","first-page":"68","article-title":"Vascular Cognitive Impairment (VCI)","volume":"19","author":"Rundek","year":"2022","journal-title":"Neurother. J. Am. Soc. Exp. Neurother."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.22543\/7674.51.P715","article-title":"Vascular Neurocognitive Disorders and the Vascular Risk Factors","volume":"5","author":"Albu","year":"2018","journal-title":"J. Mind Med. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.neuron.2013.10.008","article-title":"The pathobiology of vascular dementia","volume":"80","author":"Iadecola","year":"2013","journal-title":"Neuron"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jalz.2013.12.025","article-title":"Aggregate effects of vascular risk factors on cerebrovascular changes in autopsy-confirmed alzheimer\u2019s disease","volume":"11","author":"Bangen","year":"2014","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_47","first-page":"e056081","article-title":"A meta-analysis of genome-wide association studies identifies new genetic loci associated with all-cause and vascular dementia","volume":"17","author":"Fongang","year":"2022","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1474-4422(09)70127-9","article-title":"Cadasil","volume":"8","author":"Chabriat","year":"2009","journal-title":"Lancet Neurol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1038\/jcbfm.2012.123","article-title":"Cadasil mutations and shrna silencing of notch3 affect actin organization in cultured vascular smooth muscle cells","volume":"32","author":"Tikka","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ana.10040","article-title":"Dementia in hereditary cerebral hemorrhage with amyloidosis-dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles","volume":"50","author":"Haan","year":"2001","journal-title":"Ann. Neurol."},{"key":"ref_51","first-page":"100124","article-title":"Main features of hereditary cerebral amyloid angiopathies: A systematic review","volume":"3","author":"Biffi","year":"2022","journal-title":"Cereb. Circ.\u2014Cogn. Behav."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e513","DOI":"10.1161\/STROKEAHA.110.581918","article-title":"COL4A1 mutations as a monogenic cause of cerebral small vessel disease: A systematic review","volume":"41","author":"Lanfranconi","year":"2010","journal-title":"Stroke"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1212\/WNL.0000000000001803","article-title":"Characteristic features and progression of abnormalities on MRI for CARASIL","volume":"85","author":"Nozaki","year":"2015","journal-title":"Neurology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.08.010","article-title":"Prevalence of Fabry disease in stroke patients\u2014A systematic review and meta-analysis","volume":"23","author":"Shi","year":"2014","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ajmg.b.30217","article-title":"Analysis of the srebf2 gene as a genetic risk factor for vascular dementia","volume":"139B","author":"Kim","year":"2005","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13024-016-0138-8","article-title":"Glymphatic distribution of CSF-derived apoE is isoform specific and suppressed during sleep deprivation","volume":"11","author":"Achariyar","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1212\/WNL.0b013e31829bfda4","article-title":"APOE genotype and MRI markers of cerebrovascular disease: Systematic review and meta-analysis","volume":"81","author":"Schilling","year":"2013","journal-title":"Neurology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline","volume":"581","author":"Montagne","year":"2020","journal-title":"Nature"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jns.2010.04.001","article-title":"The MTHFR C677T polymorphism contributes to an increased risk for vascular dementia: A meta-analysis","volume":"294","author":"Liu","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","article-title":"A meta-analysis of cytokines in Alzheimer\u2019s disease","volume":"68","author":"Swardfager","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/alz.12157","article-title":"Vascular contributions to cognitive impairment and dementia (VCID): A report from the 2018 National Heart, Lung, and Blood Institute and National Institute of Neurological Disorders and Stroke Workshop","volume":"16","author":"Zlokovic","year":"2020","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nrneurol.2015.10","article-title":"White matter hyperintensities, cognitive impairment and dementia: An update","volume":"11","author":"Prins","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12974-019-1516-2","article-title":"Neuroinflammation: Friend and foe for ischemic stroke","volume":"16","author":"Jayaraj","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/HYPERTENSIONAHA.113.01063","article-title":"Hypertension: A harbinger of stroke and dementia","volume":"62","author":"Faraco","year":"2013","journal-title":"Hypertension"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/brain\/aww008","article-title":"White matter hyperintensities and imaging patterns of brain ageing in the general population","volume":"139","author":"Habes","year":"2016","journal-title":"Brain"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S1474-4422(22)00208-3","article-title":"The Boston criteria version 2.0 for cerebral amyloid angiopathy: A multicentre, retrospective, MRIneuropathology diagnostic accuracy study","volume":"21","author":"Charidimou","year":"2022","journal-title":"Lancet Neurol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"a016345","DOI":"10.1101\/cshperspect.a016345","article-title":"Inflammation and the blood microvascular system","volume":"7","author":"Pober","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/sj.jcbfm.9600375","article-title":"Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat","volume":"27","author":"Yang","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"242","DOI":"10.14802\/jmd.20039","article-title":"An Autopsy-Proven Case of Lewy Body Disease Presenting with Severe Dysphagia","volume":"14","author":"Jo","year":"2021","journal-title":"J. Mov. Disord."},{"key":"ref_70","first-page":"216","article-title":"Regional Overlap of Pathologies in Lewy Body Disorders","volume":"76","author":"Planellas","year":"2017","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","article-title":"The Sydney multicenter study of Parkinson\u2019s disease: The inevitability of dementia at 20 years","volume":"23","author":"Hely","year":"2008","journal-title":"Mov. Disord."},{"key":"ref_72","unstructured":"Haider, A., Spurling, B.C., and S\u00e1nchez-Manso, J.C. (2023). Lewy Body Dementia. StatPearls, StatPearls Publishing."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"101441","DOI":"10.1016\/j.disamonth.2022.101441","article-title":"Recent advances in Lewy body dementia: A comprehensive review","volume":"69","author":"Prasad","year":"2023","journal-title":"Dis.-A-Mon"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1017\/S0033291713000494","article-title":"The prevalence and incidence of dementia with Lewy bodies: A systematic review of population and clinical studies","volume":"44","year":"2014","journal-title":"Psychol. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cger.2018.06.007","article-title":"Lewy Body Dementia","volume":"34","author":"Sanford","year":"2018","journal-title":"Clin. Geriatr. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1474-4422(03)00619-7","article-title":"Dementia with Lewy bodies","volume":"3","author":"McKeith","year":"2004","journal-title":"Lancet Neurol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1385\/JMN:17:2:225","article-title":"Lewy body pathology in Alzheimer\u2019s disease","volume":"17","author":"Kotzbauer","year":"2001","journal-title":"J. Mol. Neurosci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13024-019-0306-8","article-title":"Dementia with Lewy bodies: An update and outlook","volume":"14","author":"Outeiro","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Uemura, N., Marotta, N., Ara, J., Meymand, E., Zhang, B., Kameda, H., Koike, M., Luk, K., Trojanowski, J., and Lee, V. (2023). Distinct biological activity of Lewy body \u03b1-Synuclein strain in mice. Res. Sq., rs.3.rs\u20132579805.","DOI":"10.21203\/rs.3.rs-2579805\/v1"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/jnc.13570","article-title":"The contribution of alpha synuclein to neuronal survival and function\u2014Implications for Parkinson\u2019s disease","volume":"137","author":"Benskey","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/mds.27355","article-title":"Biomarkers for cognitive impairment in Lewy body disorders: Status and relevance for clinical trials","volume":"33","author":"Siderowf","year":"2018","journal-title":"Mov. Disord."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2174\/138920308785915218","article-title":"Alpha-synuclein misfolding and neurodegenerative diseases","volume":"9","author":"Uversky","year":"2008","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1474-4422(17)30400-3","article-title":"Investigating the genetic architecture of dementia with lewy bodies: A two-stage genome-wide association study","volume":"17","author":"Guerreiro","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s40478-020-01033-1","article-title":"Assessment of genetic risk for improved clinical-neuropathological correlations","volume":"8","author":"Spencer","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"fcae190","DOI":"10.1093\/braincomms\/fcae190","article-title":"Investigation of the genetic aetiology of lewy body diseases with and without dementia","volume":"6","author":"Wu","year":"2023","journal-title":"Brain Commun."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Hansen, D., Ling, H., Lashley, T., Holton, J., and Warner, T. (2019). Review: Clinical, neuropathological and genetic features of lewy body dementias. Neuropathol. Appl. Neurobiol., 45, 635\u2013654.","DOI":"10.1111\/nan.12554"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.nbd.2016.06.004","article-title":"Next-generation sequencing reveals substantial genetic contribution to dementia with lewy bodies","volume":"94","author":"Geiger","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e728","DOI":"10.1038\/tp.2015.220","article-title":"Exome sequencing in dementia with lewy bodies","volume":"6","author":"Keogh","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Ahmad, M.A., Kareem, O., Khushtar, M., Akbar, M., Haque, M.R., Iqubal, A., Haider, M.F., Pottoo, F.H., Abdulla, F.S., and Al-Haidar, M.B. (2022). Neuroinflammation: A Potential Risk for Dementia. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23020616"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1096\/fj.08-123877","article-title":"Accumulation of tau induced in neurites by microglial proinflammatory mediators","volume":"23","author":"Gorlovoy","year":"2009","journal-title":"FASEB J."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","article-title":"Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: From overt neurodegeneration back to early synaptic dysfunction","volume":"14","author":"Calabresi","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1192\/bjp.bp.110.090373","article-title":"Visual hallucinations in dementia with lewy bodies: Transcranial magnetic stimulation study","volume":"199","author":"Taylor","year":"2011","journal-title":"Br. J. Psychiatry"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(16)00737-6","article-title":"The frontotemporal dementia-motor neuron disease continuum","volume":"388","author":"Burrell","year":"2016","journal-title":"Lancet"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ncl.2017.01.008","article-title":"Frontotemporal Dementia","volume":"35","author":"Olney","year":"2017","journal-title":"Neurol. Clin."},{"key":"ref_95","first-page":"968","article-title":"Frontotemporal dementia\u2014Features, diagnosis and management","volume":"40","author":"Chan","year":"2011","journal-title":"Aust. Fam. Physician"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3233\/JAD-170584","article-title":"Biological, Neuroimaging, and Neurophysiological Markers in Frontotemporal Dementia: Three Faces of the Same Coin","volume":"62","author":"Borroni","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/bs.irn.2019.10.012","article-title":"Parkinsonism in frontotemporal dementias","volume":"149","author":"Rowe","year":"2019","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","article-title":"Classification of primary progressive aphasia and its variants","volume":"76","author":"Hillis","year":"2011","journal-title":"Neurology"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia","volume":"134","author":"Rascovsky","year":"2011","journal-title":"Brain"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Johnen, A., and Bertoux, M. (2019). Psychological and Cognitive Markers of Behavioral Variant Frontotemporal Dementia-A Clinical Neuropsychologist\u2019s View on Diagnostic Criteria and Beyond. Front. Neurol., 10.","DOI":"10.3389\/fneur.2019.00594"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/brain\/awr355","article-title":"Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations","volume":"135","author":"Snowden","year":"2012","journal-title":"Brain"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3233\/JAD-140312","article-title":"Psychosis in frontotemporal dementia","volume":"42","author":"Shinagawa","year":"2014","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1017\/S1041610214002580","article-title":"Psychotic symptoms in frontotemporal dementia: A diagnostic dilemma?","volume":"27","author":"Gustafson","year":"2015","journal-title":"Int. Psychogeriatr."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S1474-4422(07)70266-1","article-title":"Semantic dementia: A unique clinicopathological syndrome","volume":"6","author":"Hodges","year":"2007","journal-title":"Lancet Neurol."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Rossi, G., Salvi, E., Mehmeti, E., Ricci, M., Villa, C., Prioni, S., Moda, F., Di Fede, G., Tiraboschi, P., and Redaelli, V. (2022). Semantic and right temporal variant of FTD: Next generation sequencing genetic analysis on a single-center cohort. Front. Aging Neurosci., 14.","DOI":"10.3389\/fnagi.2022.1085406"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1212\/WNL.0b013e3181ed9c6b","article-title":"Syndromes of nonfluent primary progressive aphasia: A clinical and neurolinguistic analysis","volume":"75","author":"Rohrer","year":"2010","journal-title":"Neurology"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1212\/01.wnl.0000436070.28137.7b","article-title":"Classification and pathology of primary progressive aphasia","volume":"81","author":"Harris","year":"2013","journal-title":"Neurology"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/bpa.12486","article-title":"Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype","volume":"27","author":"Mann","year":"2017","journal-title":"Brain Pathol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1212\/WNL.59.7.1077","article-title":"The overlap of amyotrophic lateral sclerosis and frontotemporal dementia","volume":"59","author":"Anderson","year":"2002","journal-title":"Neurology"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neulet.2007.05.049","article-title":"Extrapyramidal symptoms in Frontotemporal Dementia: Prevalence and clinical correlations","volume":"422","author":"Padovani","year":"2007","journal-title":"Neurosci. Lett."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrneurol.2012.117","article-title":"Advances in understanding the molecular basis of frontotemporal dementia","volume":"8","author":"Rademakers","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"ref_112","unstructured":"Khan, I., and De Jesus, O. (2023). Frontotemporal Lobe Dementia. StatPearls, StatPearls Publishing."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/s41374-019-0197-x","article-title":"Mapt mutations, tauopathy, and mechanisms of neurodegeneration","volume":"99","author":"Strang","year":"2019","journal-title":"Lab. Investig."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41586-021-03911-7","article-title":"Structure-based classification of tauopathies","volume":"598","author":"Shi","year":"2021","journal-title":"Nature"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s12031-011-9589-0","article-title":"Neuropathology of frontotemporal lobar degeneration-tau (ftld-tau)","volume":"45","author":"Dickson","year":"2011","journal-title":"J. Mol. Neurosci."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1001\/jamaneurol.2013.114","article-title":"Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism","volume":"70","author":"Savica","year":"2013","journal-title":"JAMA Neurol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/brain\/aws001","article-title":"Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics","volume":"135","author":"Whitwell","year":"2012","journal-title":"Brain"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/jnnp-2020-323698","article-title":"In vivo pet imaging of neuroinflammation in familial frontotemporal dementia","volume":"92","author":"Malpetti","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/acn3.51165","article-title":"Adeno-associated virus serotype 1-based gene therapy for FTD caused by GRN mutations","volume":"7","author":"Hinderer","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/brain\/awx060","article-title":"Restoring neuronal progranulin reverses deficits in a mouse model of frontotemporal dementia","volume":"140","author":"Arrant","year":"2017","journal-title":"Brain"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00401-014-1380-1","article-title":"Frontotemporal lobar degeneration: Defining phenotypic diversity through personalized medicine","volume":"129","author":"Irwin","year":"2014","journal-title":"Acta Neuropathol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neurobiolaging.2017.10.008","article-title":"Patterns of gray matter atrophy in genetic frontotemporal dementia: Results from the genfi study","volume":"62","author":"Cash","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1093\/brain\/awac446","article-title":"Neurodevelopmental effects of genetic frontotemporal dementia in young adult mutation carriers","volume":"146","author":"Finger","year":"2022","journal-title":"Brain"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3233\/JAD-170066","article-title":"Frontotemporal dementia due to the novel grn arg161glyfsx36 mutation","volume":"57","author":"Gazzina","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","article-title":"ApoE in Alzheimer\u2019s disease: Pathophysiology and therapeutic strategies","volume":"17","author":"Raulin","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"ref_126","first-page":"201","article-title":"Amyloid Precursor Protein: A Regulatory Hub in Alzheimer\u2019s Disease","volume":"15","author":"Chen","year":"2024","journal-title":"Aging Dis."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Huang, W., Huang, J., Huang, N., and Luo, Y. (2023). The role of TREM2 in Alzheimer\u2019s disease: From the perspective of Tau. Front. Cell Dev. Biol., 11.","DOI":"10.3389\/fcell.2023.1280257"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/1533317513518653","article-title":"A Novel Presenilin 1 Mutation in Early-Onset Alzheimer\u2019s Disease with Prominent Frontal Features","volume":"29","author":"Nygaard","year":"2014","journal-title":"Am. J. Alzheimer\u2019s Dis. Other Dement."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Robbins, J.P., Perfect, L., Ribe, E.M., Maresca, M., Dangla-Valls, A., Foster, E.M., Killick, R., Nowosiad, P., Reid, M.J., and Polit, L.D. (2018). Clusterin Is Required for \u03b2-Amyloid Toxicity in Human iPSC-Derived Neurons. Front. Neurosci., 12.","DOI":"10.3389\/fnins.2018.00504"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/glia.24355","article-title":"Complement receptor 1 is expressed on brain cells and in the human brain","volume":"71","author":"Daskoulidou","year":"2023","journal-title":"Glia"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat. Genet."},{"key":"ref_132","unstructured":"Ando, K., Tomimura, K., Sazdovitch, V., Suain, V., Yilmaz, Z., Authelet, M., Ndjim, M., Vergara, C., Belkouch, M., and Potier, M. (2016, January 8). Clathrin adaptor CALM\/PICALM is involved in tau pathology in Alzheimer and other tauopathies. Proceedings of the Conference Abstract: 6th Belgian Brain Congress, Mons, Belgium."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00401-023-02670-1","article-title":"A familial missense variant in the Alzheimer\u2019s disease gene SORL1 impairs its maturation and endosomal sorting","volume":"147","author":"Fazeli","year":"2024","journal-title":"Acta Neuropathol."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Duong, M.T., Nasrallah, I.M., Wolk, D.A., Chang, C.C.Y., and Chang, T.Y. (2021). Cholesterol, Atherosclerosis, and APOE in Vascular Contributions to Cognitive Impairment and Dementia (VCID): Potential Mechanisms and Therapy. Front. Aging Neurosci., 13.","DOI":"10.3389\/fnagi.2021.647990"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MOH.0000000000000502","article-title":"Emerging molecular mechanisms of vascular dementia","volume":"26","author":"Romay","year":"2019","journal-title":"Curr. Opin. Hematol."},{"key":"ref_136","first-page":"e12612","article-title":"Vascular endothelial growth factor is an effective biomarker for vascular dementia, not for Alzheimer\u2019s disease: A meta-analysis","volume":"16","author":"Xu","year":"2024","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"117575","DOI":"10.1016\/j.biopha.2024.117575","article-title":"The potential role of transcription factor sterol regulatory element binding proteins (SREBPs) in Alzheimer\u2019s disease","volume":"180","author":"Liu","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13024-025-00868-3","article-title":"Alpha-synuclein seeding amplification assays in Lewy body dementia: A brief review","volume":"20","author":"Bregendahl","year":"2025","journal-title":"Mol. Neurodegener."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1093\/brain\/awu119","article-title":"Convergence of pathology in dementia with Lewy bodies and Alzheimer\u2019s disease: A role for the novel interaction of alpha-synuclein and presenilin 1 in disease","volume":"137","author":"Winslow","year":"2014","journal-title":"Brain"},{"key":"ref_140","first-page":"1163","article-title":"Mutations in presenilin 2 and its implications in Alzheimer\u2019s disease and other dementia-associated disorders","volume":"10","author":"Cai","year":"2015","journal-title":"Clin. Interv. Aging"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S1474-4422(25)00363-1","article-title":"Advances in the genetics and pathology of Lewy body dementia","volume":"24","author":"Scholz","year":"2025","journal-title":"Lancet. Neurol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"107957","DOI":"10.1016\/j.phrs.2025.107957","article-title":"Frontotemporal dementia as a consequence of GRN mutations: From disease cause to models to therapies","volume":"221","author":"Salzano","year":"2025","journal-title":"Pharmacol. Res."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Vinceti, G., Gallingani, C., Zucchi, E., Martinelli, I., Gianferrari, G., Simonini, C., Bedin, R., Chiari, A., Zamboni, G., and Mandrioli, J. (2023). Young Onset Alzheimer\u2019s Disease Associated with C9ORF72 Hexanucleotide Expansion: Further Evidence for a Still Unsolved Association. Genes, 14.","DOI":"10.3390\/genes14040930"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"fcad234","DOI":"10.1093\/braincomms\/fcad234","article-title":"Genetic risks of Alzheimer\u2019s by APOE and MAPT on cortical morphology in young healthy adults","volume":"5","author":"Huang","year":"2023","journal-title":"Brain Commun."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00401-015-1475-3","article-title":"Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology","volume":"130","author":"Clayton","year":"2015","journal-title":"Acta Neuropathol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00415-020-10283-x","article-title":"SQSTM1 variant in disorders of the frontotemporal dementia\u2013amyotrophic lateral sclerosis spectrum: Identification of a novel heterozygous variant and a review of the literature","volume":"268","author":"Li","year":"2021","journal-title":"J. Neurol."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Shao, F., Wang, X., Wu, H., Wu, Q., and Zhang, J. (2022). Microglia and Neuroinflammation: Crucial Pathological Mechanisms in Traumatic Brain Injury-Induced Neurodegeneration. Front. Aging Neurosci., 14.","DOI":"10.3389\/fnagi.2022.825086"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s12276-025-01450-z","article-title":"Microglia-driven inflammation induces progressive tauopathies and synucleinopathies","volume":"57","author":"Lee","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Morales, I., Far\u00edas, G.A., Cortes, N., and Maccioni, R.B. (2016). Neuroinflammation and Neurodegeneration. Update on Dementia, IntechOpen.","DOI":"10.5772\/64545"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1007\/s12035-018-1283-6","article-title":"Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation","volume":"56","author":"Doorduin","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2174\/187152710791012053","article-title":"Assessing activation states in microglia","volume":"9","author":"Colton","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1007\/s11064-012-0751-z","article-title":"Acacetin attenuates neuroinflammation via regulation the response to LPS stimuli in vitro and in vivo","volume":"37","author":"Ha","year":"2012","journal-title":"Neurochem. Res."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.expneurol.2004.08.008","article-title":"Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier","volume":"190","author":"Wong","year":"2004","journal-title":"Exp. Neurol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"8354","DOI":"10.1523\/JNEUROSCI.0616-08.2008","article-title":"Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer\u2019s disease mice","volume":"28","author":"Hickman","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(01)05625-2","article-title":"In-vivo measurement of activated microglia in dementia","volume":"358","author":"Cagnin","year":"2001","journal-title":"Lancet"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/nen.0b013e31812503e1","article-title":"Common inflammatory mechanisms in Lewy body disease and Alzheimer disease","volume":"66","author":"Mrak","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1523\/JNEUROSCI.4361-12.2013","article-title":"Sustained interleukin-1\u03b2 overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer\u2019s mouse model","volume":"33","author":"Ghosh","year":"2013","journal-title":"J. Neurosci."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuint.2014.04.001","article-title":"Peripheral administration of an anti-TNF-\u03b1 receptor fusion protein counteracts the amyloid induced elevation of hippocampal TNF-\u03b1 levels and memory deficits in mice","volume":"72","author":"Detrait","year":"2014","journal-title":"Neurochem. Int."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3233\/JAD-140177","article-title":"Increased plasma TACE activity in subjects with mild cognitive impairment and patients with Alzheimer\u2019s disease","volume":"41","author":"Sun","year":"2014","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1179573517709278","DOI":"10.1177\/1179573517709278","article-title":"Tumor necrosis factor \u03b1 Inhibition for Alzheimer\u2019s Disease","volume":"9","author":"Chang","year":"2017","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.neurobiolaging.2008.10.012","article-title":"Soluble TNF receptors are associated with A\u03b2 metabolism and conversion to dementia in subjects with mild cognitive impairment","volume":"31","author":"Buchhave","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2353\/ajpath.2007.060378","article-title":"Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice","volume":"170","author":"Yamamoto","year":"2007","journal-title":"Am. J. Pathol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"49523","DOI":"10.1074\/jbc.M402034200","article-title":"Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway","volume":"279","author":"Liao","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","article-title":"The pro- and anti-inflammatory properties of the cytokine interleukin-6","volume":"1813","author":"Scheller","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000474940","article-title":"Serum Interleukin-10 Levels Correlate with Cerebrospinal Fluid Amyloid Beta Deposition in Alzheimer Disease Patients","volume":"17","author":"Fabris","year":"2017","journal-title":"Neuro-Degener. Dis."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00441-011-1230-6","article-title":"Dysfunction of TGF-\u03b21 signaling in Alzheimer\u2019s disease: Perspectives for neuroprotection","volume":"347","author":"Caraci","year":"2012","journal-title":"Cell Tissue Res."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41591-019-0695-9","article-title":"Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer\u2019s disease","volume":"26","author":"Zhou","year":"2020","journal-title":"Nat. Med."},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Singh, A., Kukreti, R., Saso, L., and Kukreti, S. (2019). Oxidative Stress: A Key Modulator in Neurodegenerative Diseases. Molecules, 24.","DOI":"10.3390\/molecules24081583"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neurobiolaging.2021.07.014","article-title":"Emerging roles of oxidative stress in brain aging and Alzheimer\u2019s disease","volume":"107","author":"Cotman","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Tian, Z., Ji, X., and Liu, J. (2022). Neuroinflammation in Vascular Cognitive Impairment and Dementia: Current Evidence, Advances, and Prospects. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23116224"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1089\/dna.2020.6186","article-title":"The Role of Autophagy in Hypoxia-Induced Neuroinflammation","volume":"40","author":"Sha","year":"2021","journal-title":"DNA Cell Biol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neures.2013.10.004","article-title":"Neuroinflammation: The role and consequences","volume":"79","author":"Lyman","year":"2014","journal-title":"Neurosci. Res."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.neuroscience.2015.03.033","article-title":"Ecto-5\u2032-nucleotidase (CD73) is involved in chronic cerebral hypoperfusion-induced white matter lesions and cognitive impairment by regulating glial cell activation and pro-inflammatory cytokines","volume":"297","author":"Hou","year":"2015","journal-title":"Neuroscience"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"a020479","DOI":"10.1101\/cshperspect.a020479","article-title":"Oligodendrocytes: Myelination and Axonal Support","volume":"8","author":"Simons","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"74","DOI":"10.7150\/thno.35841","article-title":"Microglia exacerbate white matter injury via complement C3\/C3aR pathway after hypoperfusion","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.brainres.2009.12.043","article-title":"Microglia transplantation attenuates white matter injury in rat chronic ischemia model via matrix metalloproteinase-2 inhibition","volume":"1316","author":"Narantuya","year":"2010","journal-title":"Brain Res."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nm.3913","article-title":"Neutrophils promote Alzheimer\u2019s disease-like pathology and cognitive decline via LFA-1 integrin","volume":"21","author":"Zenaro","year":"2015","journal-title":"Nat. Med."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0022-510X(95)00116-J","article-title":"Chronic brain ischemia: The contributions of Otto Binswanger and Alois Alzheimer to the mechanisms of vascular dementia","volume":"132","author":"Mast","year":"1995","journal-title":"J. Neurol. Sci."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jns.2009.05.010","article-title":"Adenosine A2A receptor deficiency exacerbates white matter lesions and cognitive deficits induced by chronic cerebral hypoperfusion in mice","volume":"285","author":"Duan","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s11604-017-0617-z","article-title":"Evaluation of glymphatic system activity with the diffusion MR technique: Diffusion tensor image analysis along the perivascular space (DTI-ALPS) in Alzheimer\u2019s disease cases","volume":"35","author":"Taoka","year":"2015","journal-title":"Jpn. J. Radiol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"ra45","DOI":"10.1126\/scisignal.2005965","article-title":"Activation of MyD88-dependent TLR1\/2 signaling by misfolded \u03b1-synuclein, a protein linked to neurodegenerative disorders","volume":"8","author":"Daniele","year":"2015","journal-title":"Sci. Signal."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/glia.22437","article-title":"Toll-like receptor 4 is required for \u03b1-synuclein dependent activation of microglia and astroglia","volume":"61","author":"Fellner","year":"2013","journal-title":"Glia"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/ncomms2534","article-title":"Neuron-released oligomeric a-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia","volume":"4","author":"Kim","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"9592","DOI":"10.1523\/JNEUROSCI.5610-12.2013","article-title":"MHCII is required for \u03b1-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration","volume":"33","author":"Harms","year":"2013","journal-title":"J. Neurosci."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/brain\/awaa033","article-title":"Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum","volume":"143","author":"Cope","year":"2020","journal-title":"Brain"},{"key":"ref_186","first-page":"21","article-title":"Imaging of neuroinflammation in dementia: A review","volume":"87","author":"Stefaniak","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Broce, I., Karch, C.M., Wen, N., Fan, C.C., Wang, Y., Tan, C.H., Kouri, N., Ross, O.A., H\u00f6glinger, G.U., and Muller, U. (2018). Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies. PLoS Med., 15, Correction in PLoS Med. 2018, 15, e1002504.","DOI":"10.1371\/journal.pmed.1002504"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13195-018-0405-8","article-title":"Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup","volume":"10","author":"Woollacott","year":"2018","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/13554794.2012.732089","article-title":"Neuropsychological, behavioral, and anatomical evolution in right temporal variant frontotemporal dementia: A longitudinal and post-mortem single case analysis","volume":"20","author":"Henry","year":"2014","journal-title":"Neurocase"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/nan.12092","article-title":"Patterns of microglial cell activation in frontotemporal lobar degeneration","volume":"40","author":"Lant","year":"2014","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0896-6273(02)00794-8","article-title":"Inflammation in neurodegenerative disease--a double-edged sword","volume":"35","author":"Mucke","year":"2002","journal-title":"Neuron"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41582-019-0231-z","article-title":"Neuroinflammation in frontotemporal dementia","volume":"15","author":"Bright","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12974-022-02573-0","article-title":"Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: Results from the GENFI study","volume":"19","author":"Heller","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/jnnp-2012-304644","article-title":"TDP-43 frontotemporal lobar degeneration and autoimmune disease","volume":"84","author":"Miller","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000322228","article-title":"Presence of reactive microglia and neuroinflammatory mediators in a case of frontotemporal dementia with P301S mutation","volume":"8","author":"Bellucci","year":"2011","journal-title":"Neuro-Degener. Dis."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.arr.2016.04.008","article-title":"Impaired protein degradation in FTLD and related disorders","volume":"32","author":"Lang","year":"2016","journal-title":"Ageing Res. Rev."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"105225","DOI":"10.1016\/j.nbd.2020.105225","article-title":"Systematic review and meta-analysis of human transcriptomics reveals neuroinflammation, deficient energy metabolism, and proteostasis failure across neurodegeneration","volume":"149","author":"Noori","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jalz.2014.08.105","article-title":"Imaging neuroinflammation in Alzheimer\u2019s disease and other dementias: Recent advances and future directions","volume":"11","author":"Varley","year":"2015","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11910-015-0531-7","article-title":"The role of neuroinflammation in dementias","volume":"15","author":"Pasqualetti","year":"2015","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrneurol.2010.17","article-title":"Microglia in neurodegenerative disease","volume":"6","author":"Perry","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: Where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s41232-025-00383-4","article-title":"Unraveling the complex role of microglia in Alzheimer\u2019s disease: Amyloid \u03b2 metabolism and plaque formation","volume":"45","author":"Takatori","year":"2025","journal-title":"Inflamm. Regen."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.expneurol.2008.04.008","article-title":"The alpha-synuclein burden hypothesis of Parkinson disease and its relationship to Alzheimer disease","volume":"212","author":"McGeer","year":"2008","journal-title":"Exp. Neurol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"key":"ref_207","doi-asserted-by":"crossref","unstructured":"Elia, L., Herting, B., Alijagic, A., Buselli, C., Wong, L., Morrison, G., Prado, M.A., Paulo, J.A., Gygi, S.P., and Finley, D. (2023). Frontotemporal Dementia Patient Neurons with Progranulin Deficiency Display Protein Dyshomeostasis. bioRxiv, bioRxiv:2023.01.18.524611.","DOI":"10.1101\/2023.01.18.524611"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"901082","DOI":"10.1155\/2013\/901082","article-title":"Serum brain-derived neurotrophic factor levels in different neurological diseases","volume":"2013","author":"Ventriglia","year":"2013","journal-title":"BioMed Res. Int."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1742-2094-11-34","article-title":"Chronic stress enhances microglia activation and exacerbates death of nigral dopaminergic neurons under conditions of inflammation","volume":"11","author":"Herrera","year":"2014","journal-title":"J. Neuroinflamm."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00401-024-02822-x","article-title":"The microglial translocator protein (TSPO) in Alzheimer\u2019s disease reflects a phagocytic phenotype","volume":"148","author":"Garland","year":"2024","journal-title":"Acta Neuropathol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"105360","DOI":"10.1016\/j.nbd.2021.105360","article-title":"Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis","volume":"154","author":"Root","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/mds.28037","article-title":"Rare Variants in Specific Lysosomal Genes Are Associated with Parkinson\u2019s Disease","volume":"35","author":"Hopfner","year":"2020","journal-title":"Mov. Disord."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.tips.2021.11.015","article-title":"Progranulin as a therapeutic target in neurodegenerative diseases","volume":"43","author":"Rhinn","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"243ra86","DOI":"10.1126\/scitranslmed.3009093","article-title":"TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis","volume":"6","author":"Kleinberger","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s12031-019-01424-7","article-title":"Analysis of Cerebrospinal Fluid Soluble TREM2 and Polymorphisms in Sporadic Parkinson\u2019s Disease in a Chinese Population","volume":"70","author":"Peng","year":"2020","journal-title":"J. Mol. Neurosci."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.neuron.2023.02.019","article-title":"Gasdermin-E mediates mitochondrial damage in axons and neurodegeneration","volume":"111","author":"Neel","year":"2023","journal-title":"Neuron"},{"key":"ref_217","first-page":"202","article-title":"Neuropsychological and functional measures of severity in Alzheimer disease, frontotemporal dementia, and semantic dementia","volume":"18","author":"Rosen","year":"2004","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ncpneuro0746","article-title":"Clinical course of neuropathologically confirmed frontal-variant Alzheimer\u2019s disease","volume":"4","author":"Taylor","year":"2008","journal-title":"Nat. Clin. practice. Neurol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s12031-011-9615-2","article-title":"Behavioral variant frontotemporal dementia with corticobasal degeneration pathology: Phenotypic comparison to bvFTD with Pick\u2019s disease","volume":"45","author":"Rankin","year":"2011","journal-title":"J. Mol. Neurosci."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1053\/j.semnuclmed.2020.12.002","article-title":"Molecular and Anatomical Imaging of Dementia with Lewy Bodies and Frontotemporal Lobar Degeneration","volume":"51","author":"Duignan","year":"2021","journal-title":"Semin. Nucl. Med."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41398-020-00954-8","article-title":"Neuroinflammation in dementia with Lewy bodies: A human post-mortem study","volume":"10","author":"Amin","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.parkreldis.2015.10.009","article-title":"Neuroinflammation in Lewy body dementia","volume":"21","author":"Surendranathan","year":"2015","journal-title":"Park. Relat. Disord."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s40478-024-01786-z","article-title":"Neuroinflammation is associated with Alzheimer\u2019s disease co-pathology in dementia with Lewy bodies","volume":"12","author":"Wetering","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/jcbfm.2012.53","article-title":"Noninvasive molecular imaging of neuroinflammation","volume":"32","author":"Jacobs","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_225","doi-asserted-by":"crossref","unstructured":"Corica, F., De Feo, M.S., Gorica, J., Sidrak, M.M.A., Conte, M., Filippi, L., Schillaci, O., De Vincentis, G., and Frantellizzi, V. (2023). PET Imaging of Neuro-Inflammation with Tracers Targeting the Translocator Protein (TSPO), a Systematic Review: From Bench to Bedside. Diagnostics, 13.","DOI":"10.3390\/diagnostics13061029"},{"key":"ref_226","doi-asserted-by":"crossref","unstructured":"Wohleb, E.S. (2016). Neuron-Microglia Interactions in Mental Health Disorders: \u201cFor Better, and For Worse\u201d. Front. Immunol., 7.","DOI":"10.3389\/fimmu.2016.00544"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.7150\/thno.25572","article-title":"Identification of new molecular targets for PET imaging of the microglial anti-inflammatory activation state","volume":"8","author":"Villa","year":"2018","journal-title":"Theranostics"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1093\/brain\/awt145","article-title":"In vivo radioligand binding to translocator protein correlates with severity of Alzheimer\u2019s disease","volume":"136","author":"Kreisl","year":"2013","journal-title":"Brain"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.1002\/alz.13455","article-title":"The potential clinical value of plasma biomarkers in Alzheimer\u2019s disease","volume":"19","author":"Blennow","year":"2023","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.biopsych.2010.08.025","article-title":"YKL-40: A novel prognostic fluid biomarker for preclinical Alzheimer\u2019s disease","volume":"68","author":"Perrin","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13024-016-0071-x","article-title":"Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer\u2019s disease","volume":"11","author":"Heslegrave","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41531-020-00147-6","article-title":"Plasma-borne indicators of inflammasome activity in Parkinson\u2019s disease patients","volume":"7","author":"Anderson","year":"2021","journal-title":"npj Park. Dis."},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Scott, X.O., Stephens, M.E., Desir, M.C., Dietrich, W.D., Keane, R.W., and de Rivero Vaccari, J.P. (2020). The Inflammasome Adaptor Protein ASC in Mild Cognitive Impairment and Alzheimer\u2019s Disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21134674"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3233\/JAD-122440","article-title":"A combination of neuropsychological, neuroimaging, and cerebrospinal fluid markers predicts conversion from mild cognitive impairment to dementia","volume":"36","author":"Olsson","year":"2013","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","article-title":"The clinical use of structural MRI in Alzheimer disease","volume":"6","author":"Frisoni","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neurobiolaging.2014.08.009","article-title":"Hippocampal volume and shape in pure subcortical vascular dementia","volume":"36","author":"Kim","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13195-020-00763-7","article-title":"Biomarker testing in MCI patients-deciding who to test","volume":"13","author":"Teunissen","year":"2021","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"e10248","DOI":"10.15252\/emmm.201810248","article-title":"Inflammasomes in neuroinflammatory and neurodegenerative diseases","volume":"11","author":"Voet","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrgastro.2015.94","article-title":"Inflammasome activation and function in liver disease","volume":"12","author":"Szabo","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_240","doi-asserted-by":"crossref","unstructured":"Liang, T., Zhang, Y., Wu, S., Chen, Q., and Wang, L. (2022). The Role of NLRP3 Inflammasome in Alzheimer\u2019s Disease and Potential Therapeutic Targets. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.845185"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbi.2016.12.014","article-title":"Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-\u03b2 and cognitive function in APP\/PS1 mice","volume":"61","author":"Dempsey","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"ref_242","first-page":"98","article-title":"Role of NLRP3 Inflammasomes in Neurodegenerative Diseases","volume":"55","year":"2023","journal-title":"Eurasian J. Med."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41531-018-0061-5","article-title":"NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson\u2019s disease","volume":"4","author":"Salas","year":"2018","journal-title":"npj Park. Dis."},{"key":"ref_244","doi-asserted-by":"crossref","unstructured":"K\u00f6rtvelyessy, P., Heinze, H.J., Prudlo, J., and Bittner, D. (2018). CSF Biomarkers of Neurodegeneration in Progressive Non-fluent Aphasia and Other Forms of Frontotemporal Dementia: Clues for Pathomechanisms?. Front. Neurol., 9.","DOI":"10.3389\/fneur.2018.00504"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/13554794.2018.1506039","article-title":"Pathological correlates of white matter hyperintensities in a case of progranulin mutation associated frontotemporal dementia","volume":"24","author":"Woollacott","year":"2018","journal-title":"Neurocase"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41582-024-00955-x","article-title":"Neurofilaments as biomarkers in neurological disorders\u2014Towards clinical application","volume":"20","author":"Khalil","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"100916","DOI":"10.1016\/j.arr.2019.100916","article-title":"Inflammation and cerebral small vessel disease: A systematic review","volume":"53","author":"Low","year":"2019","journal-title":"Ageing Res. Rev."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/S0140-6736(15)00463-8","article-title":"Vascular dementia","volume":"386","author":"Thomas","year":"2015","journal-title":"Lancet"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","article-title":"Plasma P-tau181 in Alzheimer\u2019s disease: Relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer\u2019s dementia","volume":"26","author":"Janelidze","year":"2020","journal-title":"Nat. Med."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1038\/s41467-021-23620-z","article-title":"A multicentre validation study of the diagnostic value of plasma neurofilament light","volume":"12","author":"Ashton","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1001\/jamaneurol.2021.3671","article-title":"Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum","volume":"78","author":"Benedet","year":"2021","journal-title":"JAMA Neurol."},{"key":"ref_252","doi-asserted-by":"crossref","unstructured":"Piggott, M.A. (2013). Neurochemical pathology of dementia. Oxford Medicine Online, Oxford University Press (OUP).","DOI":"10.1093\/med\/9780199644957.003.0007"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/1\/179\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T05:31:20Z","timestamp":1766813480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/1\/179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":252,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["ijms27010179"],"URL":"https:\/\/doi.org\/10.3390\/ijms27010179","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]}}}